Seattle Genetics reported $3.95B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 724.43M 30.74M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Amgen AMGN:US $ 59773M 2766M
Astellas Pharma 4503:JP Y 2249456M 24172M
Bayer BAYN:GR € 114427M 4350M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Celldex Therapeutics CLDX:US $ 204.55M 14.51M
Clovis Oncology CLVS:US $ 572.23M 23.39M
Daiichi Sankyo 4568:JP Y 2062470M 22708M
Eisai 4523:JP Y 1129341M 39332M
Esperion Therapeutics ESPR:US $ 280.46M 1.86M
Exelixis EXEL:US $ 2367.27M 176.73M
Genmab GEN:DC DK 22483M 273M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Glaxosmithkline GSK:US $ 77011M 1068M
Immunogen IMGN:US $ 301.45M 44.52M
Insmed INSM:US $ 1.23B 537.39M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Macrogenics MGNX:US $ 425.91M 9.53M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Moderna Inc MRNA:US 16.15B 3.46B
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Novartis NOVN:VX SF 124015M 2263M
Puma Biotechnology PBYI:US $ 260M 1.34M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Spectrum Pharmaceuticals SPPI:US $ 175.04M 3.96M
Takeda 4502:JP Y 12657234M 255059M
Teva Pharmaceutical TEVA:IT 49.2B 191M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
Xencor XNCR:US $ 695.6M 2.86M
YTE INCY:US $ 3904.62M 243.19M